Connection

Daniel Douek to Antibodies, Neutralizing

This is a "connection" page, showing publications Daniel Douek has written about Antibodies, Neutralizing.
Connection Strength

0.244
  1. Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variants. Science. 2021 09 17; 373(6561):1372-1377.
    View in: PubMed
    Score: 0.034
  2. Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants. N Engl J Med. 2021 08 12; 385(7):664-666.
    View in: PubMed
    Score: 0.034
  3. Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants. Science. 2021 Aug 13; 373(6556).
    View in: PubMed
    Score: 0.034
  4. Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses. Nature. 2021 06; 594(7864):553-559.
    View in: PubMed
    Score: 0.033
  5. A majority of uninfected adults show preexisting antibody reactivity against SARS-CoV-2. JCI Insight. 2021 04 22; 6(8).
    View in: PubMed
    Score: 0.033
  6. HIV Infection: Advances Toward a Cure. Top Antivir Med. 2018 Apr; 25(4):121-125.
    View in: PubMed
    Score: 0.027
  7. Functional interrogation and mining of natively paired human VH:VL antibody repertoires. Nat Biotechnol. 2018 02; 36(2):152-155.
    View in: PubMed
    Score: 0.026
  8. mRNA-1273 protects against SARS-CoV-2 beta infection in nonhuman primates. Nat Immunol. 2021 10; 22(10):1306-1315.
    View in: PubMed
    Score: 0.008
  9. Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates. Sci Transl Med. 2021 08 18; 13(607).
    View in: PubMed
    Score: 0.008
  10. Lymphoid tissue fibrosis is associated with impaired vaccine responses. J Clin Invest. 2018 07 02; 128(7):2763-2773.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.